Sugarbaker Paul H
Program in Peritoneal Surface Oncology, Center for Gastrointestinal Malignancy, MedStar Washington Hospital Center, Washington, DC, USA.
Ann Surg Oncol. 2017 Mar;24(3):729-732. doi: 10.1245/s10434-016-5632-2. Epub 2016 Oct 21.
Mucinous appendiceal neoplasms (MAN) with peritoneal dissemination is treated as a standard of care using cytoreductive surgery and hyperthermic perioperative chemotherapy. The extent of the resection of peritoneal surfaces and visceral structures is generally well defined. Exception to this consensus regarding structures to be removed are the right colon and adjacent ileocolic lymph nodes.
From a prospectively maintained database, all patients with a histologic diagnosis of peritoneal mucinous carcinoma (PMCA) who underwent complete cytoreductive surgery were assessed for the presence versus absence of adenocarcinoma in lymph nodes within the appendiceal mesentery and/or in the lymph nodes of the ileocolic group. The histologic grade of the PMCA was correlated with the incidence of lymph node invasion. Also, in those PMCA patients who had no evidence of lymph node invasion, recurrence within the ileocolic lymph nodes was determined by computed tomography or second look.
In a database of MAN patients, 299 had a histologic diagnosis of PMCA. In well-differentiated (n = 44), moderately differentiated (n = 107), and poorly differentiated (n = 148) PMCA specimens, there were 6.8, 5.6, and 29 % positive lymph nodes, respectively. None of these 151 patients with well- or moderately differentiated PMCA had a computed tomographic scan or clinical evidence by second-look surgery of recurrence within the ileocolic lymph nodes.
There is a low incidence (6.0 %) of positive lymph nodes in patients with low or moderately differentiated PMCA. With high-grade disease, lymph node invasion increased to 29.0 %. Right colectomy is indicated in patients with high-grade PMCA.
伴有腹膜播散的黏液性阑尾肿瘤(MAN)采用细胞减灭术和围手术期热化疗作为标准治疗方法。腹膜表面和内脏结构的切除范围通常定义明确。关于需切除结构的这一共识的例外情况是右半结肠和相邻的回结肠淋巴结。
从一个前瞻性维护的数据库中,对所有经组织学诊断为腹膜黏液癌(PMCA)且接受了完整细胞减灭术的患者,评估阑尾系膜内淋巴结和/或回结肠组淋巴结中腺癌的有无。将PMCA的组织学分级与淋巴结侵犯发生率相关联。此外,在那些无淋巴结侵犯证据的PMCA患者中,通过计算机断层扫描或二次探查确定回结肠淋巴结内的复发情况。
在MAN患者数据库中,299例经组织学诊断为PMCA。在高分化(n = 44)、中分化(n = 107)和低分化(n = 148)的PMCA标本中,淋巴结阳性率分别为6.8%、5.6%和29%。这151例高分化或中分化PMCA患者中,无一例通过计算机断层扫描或二次探查手术有回结肠淋巴结复发的临床证据。
低分化或中分化PMCA患者的淋巴结阳性率较低(6.0%)。对于高级别疾病,淋巴结侵犯率增至29.0%。高级别PMCA患者需行右半结肠切除术。